GSK to shut down tablet-packaging facility in Melbourne
The company has planned to shut down the facility as part of a business transformation. The jobs are expected to be axed around the end of 2014 or
Ionis Pharmaceuticals has entered a licence agreement granting global pharmaceutical company Recordati exclusive rights to develop and commercialise zilganersen to treat Alexander disease (AxD) in countries outside the US.
The company will continue evaluating the compound in other hematologic malignancies such as adult acute lymphoblastic leukemia (ALL). Pfizer’s oncology business unit clinical development and medical affairs senior